Smart biomaterials and nanotechnology

New tools for more precise drug delivery systems Kimbelery Pardo – Marketing and Business Development Analyst The pharmaceutical industry is undergoing a period of profound transformation driven by the convergence of materials science, biology, and technology. In this context, smart biomaterials and nanotechnology are emerging as key tools for the [...]

Read More
Dermocosmetic Patches

Dermocosmetic Patches: Uses, Types, and Development Opportunities for the Pharmaceutical Industry

Dermocosmetic patches are not a recent invention. More than 3,000 years ago, Chinese and Egyptian cultures were already applying pharmaceutical preparations to the skin for therapeutic purposes. What is recent is the sophistication of the format: today, that same transdermal delivery logic is applied to cosmetic actives with technical precision [...]

Read More

Intellectual Property in Pharmaceutical Products: Development Strategies in the Transdermal Segment

Since the beginning of the Modern Age, inventors and companies have sought to protect their innovations through patents — the legal instrument granting temporary exclusivity over their developments. In the pharmaceutical industry, this mechanism carries particular weight: research cycles are long, regulatory approval costs are high, and the commercial exclusivity [...]

Read More

The Microbiome and Neurodegenerative Diseases: Evidence, Limitations, and Opportunities for Transdermal CNS Development

The relationship between the gut microbiome and neurodegenerative diseases is one of the most actively researched fields of the past decade. Accumulated preclinical and clinical evidence suggests the microbiota may play a key role in susceptibility to and progression of conditions such as Parkinson's and Alzheimer's disease. At the same [...]

Read More